Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq
Other stock markets
 01:30:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
1.15 USD -4.92% Intraday chart for Inhibikase Therapeutics, Inc. -16.02% -9.41%
Jun. 17 Inhibikase Therapeutics Completes Enrollment of the Phase 2 ?201? Trial Evaluating Risvodetinib in Untreated Parkinson?s Disease CI
Jun. 05 Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INHIBIKASE THERAPEUTICS, INC. Stock Inhibikase Therapeutics, Inc.
 8.3M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 44.44B -
LONZA GROUP AG Stock Lonza Group AG
 40.03B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.68B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.46B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.29B
  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. Sector Chart